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Cell-based studies of human ribonucleases tradition-
ally rely on methods that deplete proteins slowly.
We engineered cells in which the 30/50 exoribo-
nucleases of the exosome complex, DIS3 and
EXOSC10, can be rapidly eliminated to assess their
immediate roles in nuclear RNA biology. The loss of
DIS3 has the greatest impact, causing the substantial
accumulation of thousands of transcripts within
60 min. These transcripts include enhancer RNAs,
promoter upstream transcripts (PROMPTs), and
products of premature cleavage and polyadenylation
(PCPA). These transcripts are unaffected by the rapid
loss of EXOSC10, suggesting that they are rarely tar-
geted to it. More direct detection of EXOSC10-bound
transcripts revealed its substrates to prominently
include short 30 extended ribosomal and small nucle-
olar RNAs. Finally, the 50/30 exoribonuclease,
XRN2, has little activity on exosome substrates, but
its elimination uncovers different mechanisms for
the early termination of transcription from protein-
coding gene promoters.
INTRODUCTION
The RNA exosome is a multi-subunit, 30/50 exoribonuclease-
containing complex originally discovered as being important
for rRNA processing (Mitchell et al., 1997). It also plays a crucial
role in the turnover of multiple coding and non-coding (nc) tran-
script classes (Kilchert et al., 2016; Schmid and Jensen, 2018).
Many of these transcripts, such as cryptic unstable transcripts
(CUTs) in yeast or promoter upstream transcripts/upstream anti-
sense RNAs (PROMPTs/uaRNAs) in humans, are products of
antisense transcription (Flynn et al., 2011; Preker et al., 2008;Cell R
This is an open access article undWyers et al., 2005). An additional class of ncRNAs in humans,
termed enhancer RNAs (eRNAs), are produced from divergent
transcription at intergenic enhancer sequence elements. Like
many other pervasive transcripts, eRNAs are highly sensitive to
exosome degradation (Andersson et al., 2014). More recently,
products of premature cleavage and polyadenylation (PCPA)
were also revealed as exosome substrates in mouse embryonic
stem cells (mESCs) (Chiu et al., 2018).
The structure of the exosome is similar in yeast and humans
and is composed of 9–11 key protein subunits (Gerlach et al.,
2018; Januszyk and Lima, 2014; Makino et al., 2013; Weick
et al., 2018). It possesses a catalytically inactive barrel structure
of 9-core subunits (EXO-9), arranged as a hexamer (the PH-like
ring) capped with a trimeric S1/KH ring. EXO-9 interacts with
two 30/50 exoribonucleases: EXOSC10 (Rrp6 in budding yeast)
and DIS3 (also known as Rrp44) (Makino et al., 2013). In budding
yeast, DIS3 is present in both nuclear and cytoplasmic exosome
complexes, but Rrp6 is found only in the nuclear complex (All-
mang et al., 1999b). The composition of the exosome is more
complicated in humans due to the presence of DIS3 subtypes;
however, the canonical DIS3 is predominantly found within the
nucleoplasm (Tomecki et al., 2010). Similar to Rrp6, EXOSC10
is nuclear and is enriched within the nucleolus (Tomecki et al.,
2010).While DIS3 and the core exosome components are essen-
tial in budding yeast, cells lacking Rrp6 are viable (Allmang et al.,
1999b; Briggs et al., 1998).
EXOSC10 is a member of the RNase D family and contains a
DEDD-Y active site providing distributive exoribonuclease activ-
ity (Januszyk et al., 2011). DIS3 is a processive ribonuclease
related to the RNase II/R family, possessing an RNB and N-ter-
minal PIN domain, and is capable of both exoribonuclease and
endoribonuclease activity (Lebreton et al., 2008; Schneider
et al., 2009). When interacting with the exosome complex,
Rrp6 is localized on top of the S1/KH cap, close to the entry
pore leading into the central channel passing through EXO-9,
whereas DIS3 is associated with the channel exit pore at the
opposing pole of EXO-9 (Makino et al., 2013; Wasmuth et al.,eports 26, 2779–2791, March 5, 2019 ª 2019 The Author(s). 2779
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
2014). Rrp6 can widen the entry pore leading into the central
channel of EXO-9 facilitating threading of RNAs through EXO-9
toward DIS3 (Wasmuth et al., 2014). RNA substrates entering
the S1/KH cap can also be directed to the active site of Rrp6
for trimming and degradation. Exosome activity is further
enhanced by a range of co-factors, including the helicase
MTR4 (Lubas et al., 2011; Weick et al., 2018).
Genome-wide characterization of human exosome substrates
have reported DIS3 as the main ribonuclease subunit respon-
sible for degrading PROMPTs, prematurely terminated protein-
coding transcripts, and eRNAs (Szczepinska et al., 2015). The
targets for EXOSC10 in human cells are less well characterized,
but include rRNA precursors (Macias et al., 2015; Sloan et al.,
2013). In budding yeast, the active site of Rrp6 can aid in the pro-
cessing of RNA substrates with more complex secondary struc-
tures, which is important during the maturation of precursor
rRNAs (Fromm et al., 2017). Uncovering previously unknown
RNAs has also increased our understanding of transcriptional
regulation. For example, the discovery of PROMPTs helped to
identify bi-directional transcription from most human promoters
(Preker et al., 2008).While our study was in progress, products of
PCPA were found to be stabilized by exosome loss, indicating
that a proportion of truncated protein-coding RNA precursors
are degraded (Chiu et al., 2018). This process is influenced by
the recruitment of U1 small nuclear RNA (snRNA) to pre-mRNA
andmay constitute a transcriptional checkpoint. Both PROMPTs
and PCPA products frequently have poly(A) signals (PASs) at
their 30 ends and possess poly(A) tails when the exosome is
depleted (Almada et al., 2013; Ntini et al., 2013). As such, a
PAS-dependent mechanism is proposed for attenuating their
transcription.
Studies of the exosome complex in human cells usually
involve protein depletion by RNAi, which is slow. The advantages
of rapid, versus slower, depletion include reduced opportunities
for compensatory effects and an ability to identify themost acute
substrates rather thanmore gradual accumulation of RNA during
long time periods, which could be indirect. This is also useful
when inferring how frequently a process takes place, which is
more difficult when protein depletion occurs during a period of
days. We engineered human cells for rapid, inducible degrada-
tion of EXOSC10 or DIS3. Both catalytic components are
essential, but DIS3 degrades the majority of nuclear exosome
substrates. Direct detection of EXOSC10 substrates revealed a
role in the maturation of small nucleolar RNAs (snoRNAs),remi-
niscent of the situation in budding yeast (Allmang et al.,
1999a). Finally, the 50/30 exonuclease XRN2 showed little activ-
ity on any exosome substrate. However, it promotes the early
termination of a subclass of transcription events from protein-
coding genes, suggesting a variety of such mechanisms.
RESULTS
Depletion of EXOSC10 or DIS3 Using the
Auxin-Inducible Degron System
The auxin-inducible degron (AID) system allows the rapid elimi-
nation of AID-tagged proteins upon the addition of auxin to cell
culture media (Nishimura et al., 2009). CRISPR/Cas9 was used
to C-terminally tag EXOSC10 or DIS3 with an AID (Figure 1A).2780 Cell Reports 26, 2779–2791, March 5, 2019Hygromycin or neomycin resistance markers were incorporated
into the cassettes for homology directed repair (HDR) so that bi-
allelic modification could be selected for (Eaton et al., 2018). A
P2A site, between the AID and drug markers, ensured their sep-
aration via peptide cleavage during translation (Kim et al., 2011).
This system requires expression of the plant E3 ubiquitin ligase,
Tir1, which we previously introduced stably into HCT116 cells,
chosen for their diploid karyotype.
Western blotting confirmed successful AID tagging of
EXOSC10 as a species of the predicted molecular weight
of EXOSC10-AID was detected in EXOSC10-AID cells with
native-sized protein absent (Figure 1B). This was confirmed by
the exclusive detection of native-sized EXOSC10 in parental
HCT116:TIR1 cells. A time course of auxin addition demon-
strated rapid depletion of EXOSC10-AID, which was reduced
by 97% after 60 min with native EXOSC10 insensitive to auxin.
Western blotting also showed the exclusive presence of DIS3-
AID inDIS3-AID cells and its depletion upon auxin treatment (Fig-
ure 1C). DIS3-AID is expressed at lower levels than native DIS3,
and quantitative reverse transcription and PCR showed that
there is a50% reduction in splicedDIS3-AIDmRNA (Figure 1C).
A monoclonal antibody to the AID tag also detected DIS3-AID,
which is absent from HCT116:TIR1 cells and eliminated within
60 min of auxin treatment (Figure 1D). Although DIS3-AID is
expressed at lower levels than native DIS3, it does not limit the
association of essential co-factors with the exosome core, as
we observed equal co-immunoprecipitation of EXOSC2 with
GFP-MTR4 in DIS3-AID and parental cells (Figure 1E).
To demonstrate the specificity of EXOSC10-AID and DIS3-AID
depletion, we monitored the levels of several exosome compo-
nents (EXOSC10, DIS3, EXOSC2, EXOSC3, and MTR4) in
parental, DIS3-AID, and EXOSC10-AID cells treated or not
treated with auxin (Figure 1F). Tagging EXOSC10 or DIS3 had
no impact on the levels of other exosome factors in the absence
of auxin. Auxin treatment specifically eliminated the tagged fac-
tors without co-depleting other proteins.
Rapid Depletion of EXOSC10-AID or DIS3-AID Leads to
Accumulation of Unstable RNAs
We next tested the effects of eliminating EXOSC10-AID or DIS3-
AID on some of their known substrates. To check for any adverse
effects of auxin addition or the AID tag, we added the parental
HCT116:TIR1 cells to the experimental series. Depletion of
EXOSC10 has been shown to stabilize a short 30 extended
version of the 5.8S rRNA (Allmang et al., 1999b; Briggs et al.,
1998; Schilders et al., 2007). We performed northern blotting
on total RNA isolated from EXOSC10-AID cells treated or not
treated with auxin for 60 min and probed blots for either mature
or 30 extended 5.8S rRNA (Figure 2A). 30 extended 5.8S rRNA
was weakly detected in treated and untreated HCT116:TIR1
cells and in untreated EXOSC10-AID cells. However, auxin treat-
ment of EXOSC10-AID cells induced a strong increase in its
levels. As such, acute depletion of EXOSC10 is sufficient to
reveal its RNA substrates with no apparent adverse effect of
the AID tag.
For DIS3, we analyzed the levels of 3 PROMPTs (STK11IP,
SERPINB8, and RBM39) and 1 antisense transcript (FOXP4-
AS). This was done in DIS3-AID cells treated or not treated
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Figure 1. Rapid Depletion of EXOSC10 or
DIS3 via the Auxin-Inducible Degron
(A) Schematic showing the CRISPR strategy for
modifying gene loci. Two repair cassettes were
generated containing the AID tag, a P2A cleavage
site, and either the hygromycin or neomycin
resistance marker, followed by an SV40 PAS.
Thesewere flanked by 50 and 30 homology arms for
the gene of interest.
(B) Western blotting of EXOSC10 in either parental
Tir1-expressing HCT116 (HCT116:TIR1) or
EXOSC10-AID cells. A time course of auxin addi-
tion was applied to the EXOSC10-AID cells. Equal
loading is shown by the presence of a non-specific
product (*) on the same blot.
(C) Western blotting of DIS3 in either HCT116:TIR1
or DIS3-AID cells treated or not treated for 60 min
with auxin. Tubulin was probed for as a loading
control. Quantitative reverse transcription and
PCR -derived levels of DIS3 mRNA also shown
(including standard deviations [SDs]), obtained
following normalization to glyceraldehyde 3-phos-
phate dehydrogenase (GAPDH) levels.
(D) Western blotting of DIS3 in either HCT116:TIR1
or DIS3-AID cells treated or not treated for 60 min
with auxin using an antibody to the AID tag.
Tubulin was probed for as a loading control.
(E) Co-immunoprecipitation (coIP) of GFP-MTR4
and EXOSC2 in HCT116:TIR1 or DIS3-AID cells.
Input (5%) and IP are shown. Blots were probed
with a-GFP (to detect GFP-MTR4) or a-EXOSC2.
(F) Western blotting of EXOSC10, DIS3, MTR4,
EXOSC2, EXOSC3, and as a loading control,
CPSF73 in HCT116:TRI1, DIS3-AID, or EXOSC10-
AID cells treated or not treated with auxin (1 h).
Due to the similar size of some of these proteins,
multiple blots were probed rather than using
stripping. Equal loading was confirmed by loading
control or ponceau. Pictures of individual blots are
deposited at Mendeley (see Method Details).with auxin (60 min) and in HCT116:TIR1 cells grown under the
same conditions (Figure 2B). Quantitative reverse transcription
and PCR showed no auxin-dependent changes in HCT116:TIR1
cells, as expected. PROMPT levels were similarly low in DIS3-
AID cells untreated with auxin, demonstrating that DIS3-AID is
sufficient for their normal turnover. However, auxin treatment
of DIS3-AID cells results in a large increase in all cases, confirm-
ing the effectiveness of this system.
DIS3 and EXOSC10 Are Essential in Human Cells
We next tested whether EXOSC10 and DIS3 are required for cell
viability. Colony formation assays were performed on EXOSC10-
AID or DIS3-AID cells grown in the presence and absence of
auxin and on HCT116:TIR1 cells under the same conditions.
HCT116:TIR1 cells formed a similar number of colonies in the
presence and absence of auxin, demonstrating no adverse ef-
fects of auxin on viability (Figure 2C). DIS3-AID cells formed as
many colonies as HCT116:TIR1 cells when auxin was omitted,
but their smaller size highlights a slight reduction in growth. NoDIS3-AID cell colonies formed in the presence of auxin, showing
that DIS3 is essential. EXOSC10-AID cells showed no statisti-
cally significant defect in colony formation in the absence of
auxin, compared to HCT116:TIR1 cells (Figure 2D). However,
auxin prevented the formation of EXOSC10-AID cell colonies,
showing that EXOSC10 is essential. This contrasts with budding
yeast, in which Drrp6 cells are viable (Allmang et al., 1999b).
Nuclear RNA-Seq Analysis following EXOSC10-AID or
DIS3-AID Elimination
We next analyzed the immediate impact of EXOSC10 and
DIS3 loss more globally. Nuclear RNA was extracted from
EXOSC10-AID or DIS3-AID cells that had been treated or not
treated with auxin for 1 h and performed RNA sequencing
(RNA-seq). Nuclear RNA was chosen, as we anticipated most
exosome substrates to be enriched in the nucleus. We first
analyzed PROMPTs and found an obvious accumulation upon
the loss of DIS3 (Figure 3A). Metagene analysis shows that
PROMPTs accumulate at thousands of genes when DIS3 isCell Reports 26, 2779–2791, March 5, 2019 2781
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Figure 2. Effects of DIS3/EXOSC10 Deple-
tion on RNA Substrates and Cell Viability
(A) Northern blot analysis of mature (bottom) and
30 extended (top) 5.8S rRNA performed in
HCT116:TIR1 cells and EXOSC10-AID cells
treated or not treated with auxin. Bar graph shows
quantitation expressed as a ratio of extended
to mature species. n = 3. *p < 0.05. Error bars
are SDs.
(B) Quantitative reverse transcription and PCR
detection of STK11IP, SERPINB8, FOXP4-AS, and
RBM39 PROMPTs in HCT116:TIR1 cells and
DIS3-AID cells treated or not treated with auxin
(1 h). Quantitation is expressed as relative RNA
level compared to that found in non-auxin-treated
HCT116:TIR1 cells after normalizing to ACTB
RNA. n = 3. *p < 0.05. Error bars are SDs.
(C) Colony formation assay for HCT116:TIR1 cells
and DIS3-AID cells grown with or without auxin.
Number of colonies expressed as a percentage of
those forming from HCT116:TIR1 cells grown in
the absence of auxin. Values show averages and
SDs from n = 3.
(D) As in (C), but for HCT116:TIR1 and EXOSC10-
AID cells.absent (Figure 3B). The global increase in PROMPT levels within
just 60 min of auxin treatment underscores their acute instability.
Further examination of the metaplot in Figure 3B revealed no
impact of either exosome subunit on the stability of 30 flanking re-
gion RNAs, consistent with our finding that these species are
XRN2 substrates (Eaton et al., 2018). Acute depletion of
EXOSC10 had no effect on PROMPT transcripts, suggesting
that they are not its immediate substrates.
Hundreds of intergenic transcripts were also seen upon DIS3
elimination, which were barely detectable in the absence of
auxin. We presume that these are eRNAs because separating
sequencing reads into sense and antisense strands showed their
bidirectionality (Figure 3C). Moreover, these regions have high
H3K4me1 versus H3K4me3 modified chromatin at their pro-
moter regions, as do enhancers (Andersson et al., 2014; Core
et al., 2014; Heintzman et al., 2007) (Figures S1A and S1B).2782 Cell Reports 26, 2779–2791, March 5, 2019A metagene analysis of these transcripts
confirmed the generality of the DIS3 ef-
fect and, as with PROMPTs, shows that
they are generally not substrates for
EXOSC10 (Figure 3D). Our experiment
again highlights the acute instability of
eRNAs and straightforward uncovering
of almost 1,000 examples upon DIS3
loss. This is a similar number to what
has been reported in other mammalian
cells when the exosome was depleted
during several days (Pefanis et al., 2015).
Protein-coding promoters also pro-
duce a variety of exosome substrates in
the sense direction, some of which are
generated by PCPA (Chiu et al., 2018;
Iasillo et al., 2017; Ogami et al., 2017).Truncated pre-mRNA products are readily apparent in our data
following rapid depletion of DIS3, but not when EXOSC10 is
lost (Figure 3E). A prominent example is observed for PCF11
pre-mRNA, which is subject to PCPA in mESCs (Chiu et al.,
2018). To test the generality of DIS3-mediated turnover of trun-
cated pre-mRNAs, we generated a metagene plot covering the
first intron of genes (Figure 3F). This showed an obvious
enhancement of intron 1 levels in cells depleted of DIS3, with
no effect of EXOSC10 loss observed. This effect is still evident
when intron read counts are normalized to those over the first
exon, but is diminished over the second or fourth intron (Figures
S1C–S1E). The robust accumulation of such RNAs within mi-
nutes of DIS3 loss is an important observation that underscores
the high frequency of attenuated transcription. All of the above
DIS3 effects were confirmed in an independent biological
RNA-seq replicate (Figure S2).
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Figure 3. Global Analysis of the Effects of EXOSC10 or DIS3 Loss
(A) Integrative genome viewer (IGV) browser tracks of MARS2, PPM1G, and SEPHS1PROMPT transcripts (boxed) in EXOSC10-AID andDIS3-AID cells treated or
not treated with auxin. y axis units are reads per kilobase per million (RPKM) mapped.
(B) Metagene plot of coding and non-coding genes in EXOSC10-AID and DIS3-AID cells treated or not treated with auxin. DIS3 loss shows a strong effect on
PROMPT regions (boxed).
(C) IGV browser tracks of 2 eRNA regions in EXOSC10-AID and DIS3-AID cells treated or not treated with auxin. y axis units are RPKM.
(D) Metagene plot of all eRNA-expressing regions in EXOSC10-AID and DIS3-AID cells treated or not treated with auxin.
(E) IGV browser tracks of PCF11 and PIGV in EXOSC10-AID and DIS3-AID cells treated or not treated with auxin. Both show strong upregulation of 50 pre-mRNA
upon loss of DIS3 (boxed). y axis units are RPKM.
(F) Metagene plot of all first introns in EXOSC10-AID and DIS3-AID cells treated or not treated with auxin.
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Figure 4. Analysis of Redundancy between
EXOSC10 and DIS3
(A) Quantitative reverse transcription and PCR
analysis of PPM1G, SEPHS1, and RBM39
PROMPTs in DIS3-AID or EXOSC10-AID cells
treated or not treated with auxin for 4 and 8 h.
Levels are expressed as fold change compared to
untreated cells (dotted line) following normalization
to GAPDH mRNA. n = 3. *p < 0.05 for differences
concluded on in the text. Error bars show SDs.
(B) coIP of EXOSC10 or EXOSC2 with GFP-MTR4
in EXOSC10-AID cells treated or not treated with
auxin (2 h). Input and IP are shown with blots
probed with a-GFP (to detect GFP-MTR4),
a-EXOSC10, or a-EXOSC2.
(C) Quantitative reverse transcription and PCR
analysis of PPM1G, SEPHS1, and RBM39
PROMPTs in EXOSC10-AID cells treated or not
treated with auxin for 24, 48, or 72 h. Levels are
expressed as fold change compared to untreated
cells (indicated by dotted line) following normaliza-
tion to GAPDH mRNA. n = 3. *p < 0.05. Error bars
show SDs.
(D) Quantitative reverse transcription and PCR
analysis of PPM1G, SEPHS1, and RBM39
PROMPTs in HCT116:TIR1 cells treated or not
treated with auxin for 72 h. Levels are expressed
as fold change compared to untreated cells
(indicated by dotted line) following normalization
to GAPDH mRNA. n = 3. Error bars show SDs.
(E) Quantitative reverse transcription and PCR
analysis of PPM1G, SEPHS1, and RBM39
PROMPTs in DIS3-AID cells transfected with
control or EXOSC10-specific siRNAs before
treatment or no treatment with auxin (1 h). Levels
are expressed as fold change compared to con-
trol siRNA transfected cells not treated with auxin
following normalization to GAPDH mRNA. n = 4.
*p < 0.05 for differences concluded on in the text.
Error bars show SDs.
(F) EXOSC10 immunofluorescence in untreated
DIS3-AID cells or the same cells treated with auxin
for 1, 2, 3, or 4 h. The same cells stained with
nucleolin are also shown. The red arrowheads
show EXOSC10 puncta that do not overlap with
nucleolin signal.There Is Little Redundancy between EXOSC10 and DIS3
Activity on Nucleoplasmic PROMPTs
A striking outcome of our RNA-seq data is the lack of effect of
EXOSC10 on the thousands of nucleoplasmic exosome sub-
strates degraded by DIS3. In contrast, depletion of EXOSC10
by RNAi often affects nucleoplasmic transcripts, and co-deple-
tion of EXOSC10 and DIS3 can produce synergistic effects that
imply some redundancy (Lubas et al., 2011; Tomecki et al.,
2010). To analyze the effects of EXOSC10 on nucleoplasmic
substrates more closely, we performed a more extended time
course of auxin treatment (4 and 8 h) in EXOSC10-AID or
DIS3-AID cells, followed by the quantitation of SEPHS1,
RBM39, and PPM1G PROMPTs (Figure 4A). While DIS3-AID
loss increases the levels of all 3 transcripts, none were signifi-
cantly affected by the absence of EXOSC10-AID. MTR4 associ-
ates with the exosome core whether EXOSC10-AID is present or
not, supporting the existence of functional complexes, even2784 Cell Reports 26, 2779–2791, March 5, 2019when EXOSC10 is absent (Figure 4B). We next treated
EXOSC10-AID cells for 24, 48, or 72 hwith auxin, which revealed
amild increase in PROMPTs at longer time points (Figure 4C). As
EXOSC10 effects require long-term protein depletion, this in-
crease could be due to the indirect consequences of its loss or
reflective of very occasional roles in PROMPT turnover. This is
not an indirect effect of auxin, as PROMPT levels were unaf-
fected in parental cells after 72 h of treatment (Figure 4D).
The absence of acute effects of EXOSC10 on PROMPTs
argues that DIS3 degrades them in its absence. To test this,
DIS3-AID cells were transfected with control or EXOSC10-spe-
cific small interfering RNAs (siRNAs) before treatment or no treat-
ment with auxin. Quantitative reverse transcription and PCRwas
then used to analyze the levels of SEPHS1, RBM39, and PPM1G
PROMPTs (Figure 4E). DIS3 elimination from control siRNA-
treated cells caused the upregulation of each PROMPT as ex-
pected. For RBM39, this effect was generally not as large as in
Figure 2B, which may result from the additional perturbation
caused by RNAi. EXOSC10 depletion caused an increase in
PROMPT levels, even in the presence of DIS3-AID, which is
consistent with the small effect of EXOSC10-AID loss at long
time points of auxin treatment. Auxin treatment of EXOSC10-
depleted DIS3-AID cells revealed a larger enhancement of
PROMPT levels than the depletion of either protein alone. As
such, although EXOSC10 plays little role in PROMPTRNAdegra-
dation under normal circumstances, its presence may be more
important when DIS3 levels are very low.
DIS3 Loss Disrupts Focused Nucleolar Localization of
EXOSC10
To understand why low DIS3 levels may lead to degradation of
some nucleoplasmic exosome substrates by EXOSC10, we
monitored its localization in DIS3-AID cells treated or not treated
with auxin over a time course (Figure 4F). As previously reported
(Lubas et al., 2011; Tomecki et al., 2010), EXOSC10 is nucleolar
enriched as shown by co-localization with nucleolin. DIS3-AID
loss resulted in less focused nucleolar localization of EXOSC10
(also see Figure S3A). This was not due to a breakdown of
nucleoli, as nucleolin signal showed little alteration in the same
cells. Furthermore, at extended time points of DIS3-AID loss,
we observed nucleoplasmic puncta of EXOSC10 in 25% of
cells that do not overlap with nucleolin signal. EXOSC10 localiza-
tion in DIS3-AID cells is identical to the parental cell line, and
analysis of wider fields of cells confirmed the generality of the
effects (Figures S3B and S3C). We conclude that DIS3-AID
loss disrupts the normally focused nucleolar localization of
EXOSC10, which may allow it to engage with nucleoplasmic
substrates and potentially explain the synergistic effect of
EXOSC10 and DIS3 co-depletion on PROMPTs.
EXOSC10 Is Involved in 30 Trimming of Pre-rRNA and
Pre-snoRNA Transcripts
We next wanted to identify specific substrates of EXOSC10 and
used individual-nucleotide resolution UV crosslinking and immu-
noprecipitation (iCLIP) to detect transcripts to which it directly
binds. We complemented previous iCLIP data, generated using
functional EXOSC10 (EXOSC10WT) in HEK293T cells (Macias
et al., 2015), with iCLIP using a catalytically dead version of
EXOSC10 (EXOSC10CAT) also expressed in HEK293T cells.
EXOSC10CAT contains a single substitution (D313N) previously
shown to abolish EXOSC10 activity (Januszyk et al., 2011). We
reasoned that EXOSC10CAT would associate more stably with
EXOSC10 substrates and facilitate their detection.
As EXOSC10 loss leads to the accumulation of 30 extended
5.8S rRNA (Figure 2A), we validated our iCLIP data by first as-
sessing this potential substrate. There was a strong iCLIP signal
specifically at this site in EXOSC10CAT samples, which had 33-
fold more reads than EXOSC10WT mapping within a 30-nt win-
dow downstream of 5.8S (Figure 5A). This large read density
seen in EXOSC10CAT indicates that the catalytic mutant blocks
the processing of pre-5.8S and underscores it as a bona fide
EXOSC10 substrate. The expression of inactive EXOSC10
in EXOSC10-AID cells consistently enhances the levels of
extended 5.8S RNA in a dominant-negative fashion (Figures
S4A and S4B). Read density rapidly drops beyond 30 nt down-stream of the annotated end of 5.8S rRNA, suggesting that
EXOSC10 is required only for the final nuclear trimming step.
This indicates a ribonuclease switch and is consistent with re-
constituted 5.8S rRNA maturation in budding yeast, during
which DIS3 processing is sterically inhibited by the exosome
core, necessitating handover to Rrp6 (Fromm et al., 2017;
Makino et al., 2015). Analysis of the entire 45S rDNA showed sig-
nificant CLIP density over the 50 external transcribed spacer
(ETS) in both EXOSC10WT and EXOSC10CAT (Figure S4C).
We reasoned that the 30-nt ‘‘footprint’’ downstream of the
5.8S rRNA, seen in EXOSC10CAT samples, can identify other
RNAs that are subject to final processing by EXOSC10. Obvious
30-nt footprints of CLIP density were identified in 30 flanking re-
gions of snoRNAs, with examples shown for SNORA69 and
SNORD18C in Figure 5B. Metagene analyses of the average dis-
tribution of EXOSC10 iCLIP reads over annotated snoRNAs indi-
cate that EXOSC10 engages in processing pre-snoRNAs that
are extended at their 30 ends by30 nt due to the specific enrich-
ment of CLIP density exclusively seen in the EXOSC10CAT iCLIP
dataset (Figure 5C). A majority of snoRNAs in both the SNORD
and SNORA classes showed this signature of EXOSC10CAT
binding (Figure S5A). Analysis of our RNA-seq data indepen-
dently revealed examples in which short extended snoRNA pre-
cursors are specifically stabilized by EXOSC10 loss (Figure 5D).
Overall, these data identify short 30 extended RNA precursors as
EXOSC10 substrates. The implication of EXOSC10 in human
snoRNA processing highlights conservation with budding yeast
in which Rrp6 performs a similar 30 trimming step (Allmang
et al., 1999a). We also noted examples in which longer
30 snoRNA extensions were seen in the absence of DIS3, which
is consistent with a ribonuclease handover and previous photo-
activatable ribonucleoside (PAR)-CLIP analysis (Szczepinska
et al., 2015) (Figure S5B). Finally, unlike for 30 extended snoRNA
and 5.8S rRNA, PROMPT and eRNA reads were not enriched in
the EXOSC10CAT experiment, and the exclusive expression of
inactive EXOSC10 did not stabilize PROMPTs (Figures S5C
and S5D). This further demonstrates that they are not usually
EXOSC10 substrates.
Analysis of XRN2 Regulation of Exosome-Targeted
Transcripts
Transcripts can also be degraded from their 50 end, with XRN2
being the major nuclear 50/30 exoribonuclease and having a
prominent role in transcriptional termination (Eaton et al.,
2018). Although RNAi has also been used to study XRN2, it
may not reveal its full repertoire of functions, as we suggested
previously by engineering XRN2-AID cells (Eaton et al., 2018).
To more accurately assess the impact of XRN2 on PROMPT
and eRNA degradation, we analyzed our previously published
nuclear RNA-seq from XRN2-AID cells in which XRN2 is elimi-
nated within 60 min of auxin treatment (Figure S6). There was
no general impact of XRN2 elimination on either of these tran-
script classes, indicating that they are not its substrates.
The termination of exosome substrates described here is
poorly understood, but the XRN2-AID cell line allows an
assessment of its role in the process. Accordingly, we analyzed
PROMPT regions in mammalian native elongating transcript
sequencing (mNET-seq) data that we previously generated inCell Reports 26, 2779–2791, March 5, 2019 2785
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XRN2-AID cells (Eaton et al., 2018). mNET-seq analyses the
position of RNA polymerase at single-nucleotide resolution by
sequencing the 30 end of RNA from within its active site (Nojima
et al., 2015). A comparison of typical PROMPTs (MYC and
RBM39) showed nascent transcription over these regions that
terminated within 1.5 kb of the respective promoters (Fig-
ure 6A). XRN2 elimination caused neither more reads over
the termination region nor additional reads beyond it. More
general analysis of the XRN2 impact on PROMPT termination
revealed only a very slight increase in signal at the 50-most
positions (also visible in the sense direction) (Figure 6B). There-
fore, extended PROMPT transcription is not generally apparent
in the absence of XRN2. RNA-seq consistently revealed no
general effect of XRN2 loss on PROMPT levels (Figures S6A
and S6B).
We also show that protein-coding genes produce exosome
substrates in the sense direction (Figures 3E and 3F), and we
tested the impact of XRN2 on the termination of these prod-
ucts. This analysis was performed on 4 truncated transcripts
at the PIGV, PCF11, CLIP4, and SEPHS1 genes (Figure 3E
demonstrates the DIS3 effect for PCF11 and PIGV with CLIP4
and SEPHS1 data in Figure 6C). PCF11 was chosen as it is
subject to PCPA in mESCs and has an annotated PCPA site
in humans (Ensembl I.D.: ENST00000624931.1; Chiu et al.,
2018) with the other 3 genes chosen at random. As truncated
transcripts overlap with full-length transcription, we labeled
nascent transcripts for 30 min with 4-thiouridine (4sU) following
treatment or no treatment with auxin. 4sU-labeled RNA was
then captured via biotinylation and streptavidin beads, isolating
it from material that existed before the elimination of XRN2.
Quantitative reverse transcription and PCR was then performed
using a primer pair within the DIS3-stabilized region (upstream
[US]) and another downstream (DS) of it (Figure 6D). XRN2 loss
induced a significant increase in RNA downstream of the DIS3-
stabilized region for PIGV and PCF11, but not for SEPHS1 or
CLIP4.
Premature termination may constitute a dead-end pathway or
it could compete with full-length transcription. To distinguish
these possibilities, primers were designed to detect downstream
splicing events in PCF11, PIGV, CLIP4, or SEPHS1 mRNAs in
4sU-labeled RNA isolated from XRN2-AID cells treated or not
treated with auxin (Figure 6E). XRN2 depletion significantly
increased the level of spliced mRNA from PCF11 and PIGV, sug-
gesting that some transcripts escaping PCPA-mediated termi-
nation are not dead-end products. However, spliced SEPHS1
or CLIP4 mRNA were unaffected by XRN2 loss, in line with its
lack of impact on their attenuated transcription.
Finally, the apparent difference in sensitivity of early termina-
tion to XRN2 may be influenced by the frequency of attenuated
transcription in each case. To assess this, attenuated SEPHS1,
CLIP4, PIGV, and PCF11 transcripts were assayed by quantita-
tive reverse transcription and PCR in DIS3-AID cells treated or
not treated with auxin (Figure 6F). All 4 transcripts accumulated(C) Metagene plots of iCLIP reads over the 50 or 30 regions of snoRNA genes
immediately 30 of snoRNA genes.
(D) IGV browser tracks ofSNORA48 andSNORA68 genes inEXOSC10-AID andD
30 extended versions of each (boxed) in auxin-treated EXOSC10-AID cells. y axisrobustly on the loss of DIS3, demonstrating similarly frequent
attenuation of transcription, with SEPHS1 showing the largest
effect. As such, the insensitivity of SEPHS1 and CLIP4 early
termination to XRN2 is not correlated with less frequent attenu-
ation of transcription compared to PCF11 and PIGV. We
conclude that DIS3 is involved in the widespread degradation
of attenuated transcripts from protein-coding genes that fall
into subtly different classes. We have distinguished some of
these on the basis of their sensitivity to XRN2-dependent
termination.
DISCUSSION
We have engineered conditional depletion of DIS3, EXOSC10, or
XRN2 to assess their immediate impact on RNAmetabolism. The
rapid depletion achieved provides important insights that com-
plement previous RNAi approaches. Timescales of minutes
versus days have the obvious advantage that transcripts are
less likely to appear through secondary effects. Moreover, an
accumulation of RNA within minutes demonstrates constant
turnover in a way that is more difficult to infer by RNAi, during
which accumulationmay be gradual. It also highlights acute sub-
strates versus those that are only apparent after long periods of
protein depletion, as exemplified by the effect of EXOSC10 on
PROMPT levels.
We were initially concerned that the low levels of DIS3-AID
may prove problematic for assaying the impact of its loss. How-
ever, several observations mitigate this concern. First, although
DIS3 is essential, DIS3-AID cells produce as many colonies as
HCT116:TIR1 cells, although they are smaller. Second, DIS3-
AID cells have the same levels of DIS3 substrates as
HCT116:TIR1 cells when auxin is not used. Third, DIS3 sub-
strates do not accumulate upon the rapid loss of EXOSC10 ac-
tivity, underlining the specificity revealed by our approach.
Fourth, the level of other exosome components and the integrity
of the exosome are not observably different between DIS3-AID
cells and parental cells.
While PROMPTs are stabilized by RNAi of EXOSC10 from
DIS3-AID cells, no effect is observed when EXOSC10-AID is
rapidly depleted, even though bona fide substrates are stabi-
lized at this early timepoint. Long-term auxin treatment of
EXOSC10-AID cells does cause a mild increase in PROMPT
levels, suggesting that RNAi effects are due to prolonged
EXOSC10 depletion. This observation suggests that RNAs,
such as PROMPTs, are only occasionally targeted by EXOSC10
or that their slight upregulation is an indirect effect of its
long-term depletion. A lack of effect of EXOSC10 on PROMPT
(and eRNA) turnover is also underscored by our iCLIP dataset,
which showed that their recovery is not enhanced by inactivat-
ing EXOSC10 (Figure S5C). Moreover, PROMPTs are not
stabilized, even when EXOSC10 is catalytically inactive (Fig-
ure S5D). These experiments demonstrate an evolving impact
of EXOSC10 loss on transcript levels over time that may havein EXOSC10WT and EXOSC10CAT samples. There is a clear 30-nt footprint
IS3-AID cells treated or not treatedwith auxin. These show upregulation of short
units are RPKM.
Cell Reports 26, 2779–2791, March 5, 2019 2787
*
*
US              DS
PCF11
C
E F
A B
MYC PROMPT
RBM39 PROMPT
XRN2-AID –Aux
XRN2-AID +Aux
N=3293
level A
NR evitaleR
*
*
0
0.5
1
1.5
2
2.5
3
3.5
PIGV spl PCF11 spl CLIP4 spl SEPHS1 spl
XRN2-AID -Aux XRN2-AID +Aux
Spliced RNA
Re
la
v
e 
RN
A 
le
ve
l
0
2
4
6
8
10
PIGV US PCF11 US CLIP4 US SEPHS1 US
DIS3-AID -Aux DIS3-AID +Aux
0
1
2
3
4
5
6
7
XRN2-AID -Aux XRN2-AID +Aux
Re
la
v
e 
RN
A 
le
ve
l
Proxy of aenuated transcripon frequency
EXOSC10-AID -Aux
EXOSC10-AID +Aux
DIS3-AID -Aux
DIS3-AID +Aux
EXOSC10-AID -Aux
EXOSC10-AID +Aux
DIS3-AID -Aux
DIS3-AID +Aux
[0-2899]
[0-2899]
[0-2899]
[0-2899]
[0-12420]
[0-12420]
[0-12420]
[0-12420]
26kb
13kb
XRN2-AID –Aux
XRN2-AID +Aux
CLIP4
SEPHS1
US              DSDC
Figure 6. Effects of Rapid XRN2 Loss on Exosome Substrates and Early Transcriptional Termination
(A) MYC and RBM39 PROMPT region tracks in mNET-seq data obtained from XRN2-AID cells treated or not treated with auxin. y axes show signals per 108
mapped reads.
(legend continued on next page)
2788 Cell Reports 26, 2779–2791, March 5, 2019
an indirect explanation that should be considered when inter-
preting data from its long-term depletion.
Our experiments do show some role for EXOSC10 in PROMPT
turnover whenDIS3 is lost asmislocalization of EXOSC10 occurs
when DIS3-AID is depleted and co-depletion of both proteins
synergistically enhances PROMPT levels. Given the nucleolar
enrichment of EXOSC10, it may be lacking in a large fraction of
nucleoplasmic exosome complexes, explaining its limited
impact on PROMPTs and other DIS3 substrates. Reciprocally,
DIS3 shows relative exclusion from nucleoli, raising the possibil-
ity of compartment-specific catalytic complexes (Tomecki et al.,
2010). We show that EXOSC10 is not required for MTR4 to asso-
ciate with the exosome core, as judged by its continued immu-
noprecipitation with EXOSC2 in auxin-treated EXOSC10-AID
cells. This is resonant with recent structural data demonstrating
that MTR4 contacts the human exosome viaMPP6 and EXOSC2
and explains how a lack of EXOSC10 is compatible with the
continued degradation of transcripts by DIS3 (Weick et al.,
2018).
As it was initially difficult to identify EXOSC10 substrates from
our RNA-seq data, we used iCLIP to detect RNAs directly bound
by EXOSC10. This was facilitated by using the inactive protein,
which revealed that signatures of EXOSC10 bound more
robustly than the wild-type protein. There was an obvious pre-
dominance of short (30 nt) extended precursors to 5.8S
rRNA, which we also saw by northern blotting. The sharp reduc-
tion of iCLIP reads beyond this 30-nt footprint strongly suggests
that EXOSC10 is involved in a final nuclear trimming step, similar
to what has been shown in budding yeast (Allmang et al.,
1999a). Structural studies lend support to this hypothesis, hav-
ing shown that bulky RNA particles can become stalled at the
entrance to the central channel of the exosome, necessitating
a handover from Rrp44 to Rrp6 (Fromm et al., 2017; Schuller
et al., 2018). We suggest that handover is also required for hu-
man snoRNA processing because short extended snoRNAs
are bound by EXOSC10 and stabilized upon its loss and
because previous PAR-CLIP shows DIS3 association with
longer snoRNA precursors (Szczepinska et al., 2015). As
snoRNAs are often present in the introns of expressed genes,
stabilized extensions may often be masked by host gene reads
in RNA-seq, with iCLIP providing a more direct assessment of
their fate. We would also like to note that the exosome may
act redundantly with other snoRNA processing pathways in
humans (Berndt et al., 2012).(B)Metagene analysis of PROMPT regions (boxed) inmNET-seq data obtained fro
Signal below zero on the y axis represents antisense PROMPT transcription.
(C) Gene tracks of CLIP4 and SEPHS1 attenuated transcription in EXOSC10-A
stabilized by DIS3 loss are boxed. y axis shows RPKM.
(D) Quantitative reverse transcription and PCR analysis of premature transcription
from XRN2-AID cells treated or not treated with auxin (1 h). A gene track for PCF1
Red arrow denotes annotated PCF11 PCPA product. The same primer position
values are plotted relative to those in untreated XRN2-AID cells following normali
(E) Quantitative reverse transcription and PCR analysis of spliced PCF11, PIGV, C
treated or not treated with auxin (1 h). Graph shows quantitation where values are
spliced GAPDH mRNA levels. nR 3. *p < 0.05. Error bars show SDs.
(F) Quantitative reverse transcription and PCR quantitation of the DIS3 effect on tr
cells treated or not treatedwith auxin (1 h). Graph shows quantitation where values
to spliced GAPDH mRNA levels. nR 3. Error bars show SDs.In studying the termination of exosome-sensitive RNAs
emanating from protein-coding gene promoters, we found that
PROMPTs and some truncated sense transcripts are insensitive
to XRN2 loss. Even so,many PROMPTs harbor PASs and poly(A)
tails, and XRN2 is implicated in some antisense transcriptional
termination by mNET-seq (Nojima et al., 2015). However, the
detection of poly(A) tails does not necessarily mean that polya-
denylation occurs on every RNA in a population, and it is possible
that truncated sense transcripts are generated in multiple ways.
A complex consisting of the cap-binding complex and ARS2 is
implicated in the 30 end processing and termination of short hu-
man transcripts, including PROMPTs (Hallais et al., 2013; Iasillo
et al., 2017). At least some ARS2-sensitive transcripts are gener-
ated by mechanisms that do not involve the canonical polyade-
nylation complex. The differential XRN2 effect on PROMPT and
truncated sense transcript termination also suggests a variety of
promoter proximal termination processes.
In summary, our data further highlight the constant and rapid
turnover of thousands of transcripts in the human nucleus and
identify specific substrates for DIS3, EXOSC10, and XRN2.
They also reveal that transcripts with apparently similar charac-
teristics (e.g., PROMPTs, PCPA products) can be subtly distin-
guished on the basis of their sensitivity to XRN2. We anticipate
that the ability to rapidly control exoribonucleases, as we have
done here, will be especially useful to interrogate processes
that cannot be dissected by long-term depletion (e.g., to test
the importance of short-lived RNAs and RNA turnover in stress
responses or other changes in cellular environments).STAR+METHODS
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Experiments involved human colon carcinoma derived HCT116 cells (male) and human embryonic kidney derived HEK293T cells
(female).
METHOD DETAILS
Cell culture and cell lines
HCT116 and HEK293T were cultured in Dulbecco modified eagle medium with 10% fetal calf serum. Our CRISPR protocol and
plasmids was described previously (Eaton et al., 2018). Sequences of EXOSC10 and DIS3 homology arms are provided in this manu-
script. Briefly, HCT116 cells grown on a 30mm dish were transfected with 1ug each of guide RNA plasmid, Neomycin and Hygrom-
ycin repair constructs. Transfection was with Jetprime (Polyplus) following the manufacturers’ guidelines. Media was changed after
24 hours and, after 72 hours, cells were re-plated into 100mm dishes in media containing 30ug/ml Hygromycin and 800ug/mlCell Reports 26, 2779–2791.e1–e5, March 5, 2019 e2
Neomycin. Resistant colonies were picked and screened by PCR 10-14 days later. Correct genomic insertion of tags was assayed by
sequencing these PCR products. Auxin was used at a concentration of 500uM for one hour unless stated otherwise. For RNAi,
24-well dishes were transfected with siRNA using Lipofectamine RNAiMax (Life Technologies) following the manufacturers’ guide-
lines. The transfection was repeated 24 hours later and, 72 hours after the first transfection, RNA was isolated.
qRT-PCR and 4sU analysis
In general 1ug of RNAwas isolated using Tri-reagent andDNase treated for one hour before reverse transcription (Protoscript II) using
random hexamers. cDNA products were diluted to 50ul volumes. 1ul was used for real-time PCR in a QIAGEN Rotorgene instrument
using Brilliant III SYBR mix (Agilent technologies). The comparative quantitation option in the software was used to generate graphs.
The 4sU qRT-PCR protocol is as described in Eaton et al., 2018.
Immunofluoresence
Cells were grown on coverslips, treated for 0, 1, 2, 3, or 4 hours with auxin, washedwith PBS, fixed for 10minutes in 4%PFA, washed
with PBS, permeabilised with 0.1% Triton x-100 (v/v in PBS) for 10 minutes, then blocked with 10% FBS (v/v in PBS) for 1 Hour. Cells
were probed overnight with 1:1000 diluted a-EXOSC10 and a-nucleolin at 4C, washed with 0.01% NP40 (v/v in PBS), probed with
Alexa Fluor 488 anti-rabbit and Alexa Fluor 555 anti-mouse secondary’s (1:2000, Invitrogen) for 1 hour, counter stainedwith DAPI,
washed and mounted. All images were taken using an Olympus-81 oil immersion microscope, exposure times, brightness and
contrast settings are identical between images.
Nuclear RNA-seq
Nuclei were extracted using hypotonic lysis buffer (10 mM Tris pH5.5, 10 mM NaCl, 2.5 mMMgCl2, 0.5% NP40) with a 10% sucrose
cushion and RNA was isolated using Tri-reagent. Following DNase treatment, RNA was Phenol Chloroform extracted and ethanol
precipitated. After assaying quality control using a Tapestation (Agilent), 1 mg RNA was rRNA-depleted using Ribo-Zero Gold
rRNA removal kit (Illumina) then cleaned and purified using RNAClean XP Beads (Beckman Coulter). Libraries were prepared using
TruSeq Stranded Total RNA Library Prep Kit (Illumina) and purified using Ampure XP beads (Beckman Coulter). A final Tapestation
D100 screen was used to determine cDNA fragment size and concentration before pooling and sequencing using Hiseq2500
(Illumina) at The University of Exeter sequencing service. GEO accession numbers: (EXOSC10-AID and DIS3-AID cell RNA-seq:
GSE120574), (XRN2-AID cell RNA-seq: GSE109003).
RNA-Seq Read Alignment
Raw single-end 50bp reads were screened for sequencing quality using FastQC; adaptor sequences were removed using Trim
Galore! and trimmed reads shorter than 20 bp were discarded. All nuclear RNA-seq analyses were carried out using the Ensembl
GRCh38.p10 and GRCh38.90 human gene annotations. Before alignment, trimmed reads were passed through the SortMeRNA
pipeline (Kopylova et al., 2012) to remove trace rRNA matching in-built 18S and 28S human databases then mapped to GRCh38 us-
ing HISAT2 (Kim et al., 2015) with default parameters supplemented with known splice sites. Unmapped, multimapped and low
MAPQ reads (< 20) were discarded from the final alignment using SAMtools (Li et al., 2009).
de novo Transcript Assembly
de novo transcripts were assembled from each library using the StringTie suite (Pertea et al., 2016) with default parameters, guided by
current GRCh38 reference annotation. Known annotated geneswere dropped and the assembled transcripts from each sample were
merged into a single consensus annotation. Reads were then counted per transcript using featureCounts (Liao et al., 2013, 2014) and
differentially expressed upregulated de novo gene intervals (R2-fold, padj < 0.05) were called using DESeq2 (Love et al., 2014).
de novo transcripts were designated as a PROMPT (< 3 kb) or eRNA (> 3 kb) based on their relative distance from the nearest
annotated gene.
Generation of Synthetic Intron Annotation
A custom intron annotation file was produced from GRCh38 by merging all exon intervals derived from each transcript isoform to
generate a synthetic transcript representative of every gene. Each synthetic exon was then subtracted from gene intervals using
the BEDtools suite (Quinlan and Hall, 2010) producing intron intervals with inherited gene information. Synthetic introns were counted
and numbered according to their strand orientation i.e., sense introns numbered ascending, antisense introns descending, finally
merging into a single annotation file.
Meta Profiling
PROMPT and eRNA Analysis
For metagene analysis, expressed protein-coding and ncRNA genes (> 50 reads per gene) were selected and an extended transcrip-
tional windowwas then applied to each gene to include a 3 kb region 50 of the TSS and a 7 kb region 30 of the TES. Overlapping genes
and genes that extended beyond chromosome ends were discarded using the BEDtools suite to prevent double read counting.
Profiles of these filtered genes were then generated from RPKM normalized reads using deeptools (Ramı´rez et al., 2014) with furthere3 Cell Reports 26, 2779–2791.e1–e5, March 5, 2019
graphical processing performed in the R environment (http://www.R-project.org). Normalized coverage plots (RPKM)were visualized
using the Integrative Genome Viewer (IGV) suite. For eRNAmeta profiles, no extendedwindowwas applied and plots were generated
directly from RPKM normalized reads and the de novo eRNA annotation file.
Peak Calling from ChIP-seq Analysis
ChIP-Seq data was generated by ENCODE from immunoprecipitation (IP) of acetylated histone 3 lysine 27 (H3K27ac) (GEO:
GSE31755), monomethylated histone 3 lysine 4 (H3K4me1) (GEO: GSE31755), trimethylated histone 3 lysine 4 (H3K4me3) (GEO:
GSE35583) and an input control sample (GEO: GSE31755) in unmodified HCT116 cells. Raw single-end ChIP-seq reads were pro-
cessed to remove adaptor sequences and low quality reads then mapped to GRCh38 using spliced alignment disabled HISAT2
parameters. BAM alignment files were converted to BED and duplicate reads were discarded and collapsed into a coverage
BEDGRAPH file. Peaks were called using MACS2 (Zhang et al., 2008). A background ChIP-Seq signal calculated from the input con-
trol sample was compared against each histone modification after sequencing depth normalization, generating a set of peaks for
each mark. Peaks were then passed through a Poisson test to call peaks with a qvalue cut-off < 0.05 producing coverage files of
peak enrichment. Enrichment of H3K4me1 and H3K4me3 marks were compared and visualized as a log2 ratio using deeptools.
Northern Blot Analysis
Total RNA was separated on a 12% Urea-PAGE gel, transferred on to a Hybond-N+ nylon membrane (GE Healthcare), dried and UV
crosslinked (2 3 1200 mjoules/cm2) before blocking in hybridization buffer (6x SSPE [150 mM NaCl, 9 mM NaH2PO4, 1 mM EDTA
(pH to 7.4], 5x Denhardt’s Reagent, 0.2% SDS) at 37C for 1 hour. DNA probes were 50 radiolabelled with [g-32P]ATP using T4
PNK (NEB) and cleaned with QIAGEN QIAquick nucleotide removal kit. Probes were then added to the hybridization buffer and incu-
bated at 42C overnight. Membranes were then rinsed in hybridization buffer 3 times for 1minute then washed at 42C for 15minutes
before drying and developing on a Phosphor screen. Imageswere developed on aGETyphoon FLA 7000 (GEHealthcare). Developed
images were then quantitated and analyzed using the ImageJ suite. Membranes were probed with the 5.8S 30 ext probe first before
stripping and re-probing with the mature 5.8S probe.
Colony Formation Assay
Cells were seeded into 100 mm cell culture plates and grown in auxin or ethanol (solvent) for 10 days. Growth media and auxin were
replaced every 2-3 days. Colonies were fixed in ice cold methanol for 10 minutes and stained using 0.5% (w/v) crystal violet + 25%
(v/v) methanol for 10 minutes. Stained colonies were counted using the ImageJ particle analyzer function. Genuine colonies were
defined as existing at a density ranging between 50-8000 pixels with a circularity rating between 0.75-1 (1 = perfect circle).
iCLIP - Experimental
3xFLAG-EXOSC10CAT was generated from 3xFLAG-EXOSC10WT using Quick-change site-directed mutagenesis kit (Stratagene) to
introduce a single amino acid change from Aspartic acid to Asparagine (D313N) within the conserved DEDD-Y motif rendering
EXOSC10 catalytically inactive. HEK293T cells were seeded into 15cm plates and transiently transfected with 3xFLAG-EXOSC10CAT
and collected 48hrs later when 90% cell confluency was reached. Cells were crosslinked twice on ice using 120 mJ/cm2 UVC irra-
diation, with ice cold PBS replaced after each cross-linking phase. iCLIP was performed on these cell pellets based on the protocol
outlined in (Ko¨nig et al., 2011). FLAG-tagged proteins were purified using M2 FLAG Dynabeads. A RNA linker (50Phosphate-
UGAGAUCGGAAGAGCGGTTCAG-30Puromycin) was ligated to the 30 end of RNAs, which was described in Ko¨nig et al. (Ko¨nig
et al., 2010). Libraries were sequenced using the Illumina HiSeq system (Bejing Genomics Institute).
iCLIP - Computational
Reads were demultiplexed, processed and PCR duplicates were collapsed using Flexbar (Dodt et al., 2012), FASTX-Toolkit (http://
hannonlab.cshl.edu/fastx_toolkit/), and custom perl scripts, respectively. Biological replicates were combined to increase coverage.
Reads were mapped to either Hg38 or a consensus sequence for 45S rDNA using Tophat with the–max-multihits 1 option called.
Genome browser files were normalized to reads per million mapped. Average distribution plots for snoRNAs were generated using
pyReadCounters.py and pyBinCollector.py from the pyCRAC software package (Webb et al., 2014). iCLIP data for 3xFLAG-
EXOSC10WT was obtained from (Macias et al., 2015; GSM1892061 and GSM1892062) and analyzed in parallel with EXOSC10CAT
data (GSE120574). SnoRNA table was generated by identifying any snoRNA that had an EXOSC10 iCLIP read mapped within
50nt DS of the 30 end of a mature snoRNA. PROMPT and eRNA annotations were derived from (Chen et al., 2016).
mNET-seq
The mNET-seq experiment and analyses pipeline are as previously published in (Eaton et al., 2018). The XRN2-AID data are depos-
ited with Gene Expression Omnibus (GSE109003).
coIP
Approximately 5 million cells were transfected with 5mg of GFP-MTR4 plasmid and the following day, lysed in IP lysis buffer (150mM
NaCl, 2.5mM MgCl2, 20mM Tris.HCl pH7.5, 1% Triton X-100) by incubation on ice for 30 mins with 1ml of Benzonase. Lysates wereCell Reports 26, 2779–2791.e1–e5, March 5, 2019 e4
clarified by centrifugation (12000rpm for 10 mins) and then incubated with 20ml GFP-TRAP beads (Chromotek) for 1 hour at 4C with
rotation. Beads were washed four times with IP lysis buffer and complexes eluted in 2x SDS gel loading buffer for analysis by western
blotting.
EXOSC10 HDR 50
TTGATCCTCCCGCCTTGGCCTCCCAGAGTACTGGGATTACAGGTGTGAGCCACTGCACCCAGCCAAATGTTTTTGTTAAAAACATA
AAATCCTAATAATTAAGCCGACCCTGAGGTCAGGGGACTTGCCCGAGGGCAGGAAAAACAGGTCTGCCTTCTCAAGATGCTGCTC
AGCTCAGCCAACTCTGGTGGGCCGCCGAGTTCTCTGGGGCCCCTGAGCAAACCATTCTTCCTCTGTTCTGCATGATTAAGATTTG
CACCATTTTGTAAACCATCTGAGAACATCCAACCAGCCCGGAAGAAATAACTGTTGTTTTTGTACTCTCTGCAGAGGCTTCAGGTAC
AACTGGCCACAGAGA
EXOSC10 HDR 30
TAGTCCTGGAAGACACGTGGCGCCTGTGGACCGGAAGCACCAAATGCTGGTGCTGCTTTTGTACATACATATTTTTAAACCATTAAA
ATTCTTCCTGAAGAAAGCTGATTCCTGACTTTTATTTTGTTGCCGCCACAGCTCTGGCAGGTTGCCATCCTGTTCAGGCAACCATCT
TCAGCTGTCTGTGGGCAGGTGAGTGTGCTCCGGGGGTTATGGTGACTTCTAGAAAAATCCAGAGCCGGCCGGGTGCGGTGGCTC
ACGCCTGCAATCCCAGCACTTTGGGAGGCTGAGGCAGGCGGATCACGAGGTCAGGAGATCGAGACCATGCTGGCCAACACGGT
GAAAGC
EXOSC10 gRNA target
AGATAGTCCTGGAAGACACG
DIS3 HDR 50
CTTGAAATCAACTCTGATTCTGTCAATCACAGTGGCTCCCCATTGGGAAGGCTGTTTTGTAGTTAAAAAGAACACTTCCTAAATGAC
ATGCTTCTCACCTGTTGAGACCATGTCTAGCTTTTACATTTTTGAACCACTGCTACTTTGTAAAATACCTTCTGTGTATAAAACCTTTA
ATTAGCCCCCTTTCCCCTCCCTACCACTACATCCTTTTAAATTTGAAGCTGGCAGTGGGGAAGGGGAGGATGAGGTTGAGATGTAT
TCTATCCTTTAAATCACCTTATTTCCCCCCATTTGCATTACTTTAGATACCAGGAATAAGCATTCCTACAGACACATCTAACATGGAC
CTTAATGGACCAAAGAAAAAGAAGATGAAGCTTGGAAAA
DIS3 HDR 30
TAGCTATATTCAACAAAAATCTTCAAAGACTGGTTTCTTTTTTAAAAGAAAAAACTTGAAAGAACACTTCTAAGCCTAAGTGTGTGATA
CAGTTTGTTACTTTTAAGTACATTTTAATAATTTCAGACATCTGCATTTTTATTGAACAGTTGACTGTATCTGACCCATCATACTACTAT
ACTTCTGGGTTGAACAGAATTATTTATGCAGAATAATTCAATTGAATATCCATCACTTAAATACAGTGACAGGACAGCAACTTCAGGG
ATCTGTAAAGATCATTTAAATGGAGT
DIS3 gRNA target
ACTGATACTTCAAACATGGA
Codon optimized IAA17 (AID)
GGTAGTGGCATGATGGGTAGTGTGGAGCTGAACCTGCGCGAGACCGAGCTGTGCTTGGGACTGCCTGGCGGCGATACGGTTGC
ACCCGTTACCGGGAACAAGAGGGGCTTCAGCGAGACAGTGGATCTCAAGCTGAATCTGAACAACGAACCTGCAAATAAAGAGGGA
AGCACCACTCATGACGTAGTGACATTCGATAGTAAAGAGAAATCTGCTTGCCCGAAGGATCCAGCTAAGCCCCCGGCCAAGGCCC
AGGTGGTGGGATGGCCCCCGGTGCGCTCCTACCGCAAAAACGTGATGGTATCATGCCAGAAAAGCAGCGGGGGGCCCGAAGCC
GCCGCTTTTGTTAAAGTGTCAATGGACGGGGCTCCATACCTGAGGAAGATCGATCTCCGGATGTACAAGTCTTACGATGAACTGAG
CAACGCGCTTTCAAACATGTTCTCATCTTTCACCATGGGAAAGCATGGGGGCGAAGAAGGAATGATTGACTTCATGAATGAGAGAA
AACTGATGGATCTCGTCAATTCTTGGGACTACGTGCCTTCATACGAGGATAAGGATGGAGATTGGATGCTGGTAGGAGACGTGCC
TTGGCCCATGTTCGTGGACACTTGCAAAAGGCTCAGACTGATGAAGGGTAGCGATGCCATCGGCTTGGCACCCCGCGCGATGGA
GAAGTGTAAATCTAGGGCC
QUANTIFICATION AND STATISTICAL ANALYSIS
qRT-PCR was quantitated using the comparative quantitation function associated with the QIAGEN Rotorgene instrument. Values
were first normalized to ACTB or GAPDH and then samples were compared by quantitating the experimental values relative to
the control condition (given the value of 1 by the software). Bars show the average of at least three replicates and error bars show
the standard deviation. Where assessed, p values were calculated using a Student’s t test.
DATA AND SOFTWARE AVAILABILITY
The accession number for the RNA-seq (EXOSC10-AID and DIS3-AID cells) and iCLIP (EXOSC10CAT) data reported in this paper is
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Figure S1: Further analysis of eRNA regions and pre-mRNA stability in EXOSC10-AID and DIS3-AID cells, 
related to Figure 3
(A) Examples of eRNA stabilised upon DIS3 loss.  These regions show bi-directional transcription (red and blue are 
signals from opposite strands) and a high level of H3K4me1 versus H3K4me3 characteristic of eRNA transcription.  Y-
axis shows RPKM for RNA-seq.  Lower panel of each figure shows H3K4me1 (blue) vs H3K4me3 (red).  H3K4me1 
density shown above the line with H3K4me3 below.  
(B) Two protein-coding genes shown for comparison with part A.  In this case, promoter regions are associated with low 
H3K4me1 but higher levels of H3K4me3.  Scales are as for A.  Both eRNA and protein-coding promoters show 
H3K27ac modification.
(C) Metagene showing enhanced reads over the first intron of genes upon auxin treatment of DIS3-AID cell lines.  
Unlike main text Figure 3F, this representation shows the intron reads normalised to read density in the upstream first 
exon which was also higher in auxin treated samples possibly because of the general stabilisation of truncated RNAs.  
For auxin treated DIS3-AID samples, read-density was therefore normalised to the average difference in exonic read-
density compared to untreated samples. Finally, both exon and intron metagene profiles were merged into a single 
profile demarcated by a dotted line.  R1 and R2 corresponds to different biological replicates of each experiment.
(D) Metagene showing RNA-seq reads across the second intron of genes in EXOSC10-AID and DIS3-AID cells treated 
or not with auxin.  The effect of DIS3 loss is diminished relative to the first introns.  The plot is not normalised to exon 1 
and generated as for Figure 3F.
(E) As for A, but for intron 4.  Note, that the effect of DIS3 loss is near absent by this stage in transcription.  The plot is 
not normalised to exon 1 and generated as for Figure 3F.
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Figure S2: Biological replicate of DIS3-AID and EXOSC10-AID RNA-seq, related to Figure 3
This figure is the same as main text figure 3 except the data are derived from a second biological repeat of the RNA-seq.  
Accordingly, annotations are the same as for main-text figure 3.
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Figure S3: Analysis of EXOSC10 localisation in HCT116:TIR1 and DIS3-AID cells treated or not with auxin, 
related to Figure 4F
(A) Immunofluorescence experiment whereby HCT116:TIR1 or DIS3-AID cells grown in the presence or absence of 
auxin (1 hr) are stained for EXOSC10 or nucleolin.  This representation is an enlarged view (of a different cell for 
DIS3-AID to highlight generality) compared to Figure 4F used to further illustrate that DIS3 loss affects EXOSC10 
staining in the nucleoli of DIS3-AID cells.  In contrast, auxin treatment of parental (HCT116:TIR1) cells does not 
impact on EXOSC10 nucleolar staining. 
(B) Immunofluorescence experiment whereby HCT116:TIR1 cells grown in the presence or absence of auxin are 
stained for EXOSC10 or nucleolin.  This experiment confirms the nucleolar location of EXOSC10 and that auxin 
treatment does not affect this.
(C) A wider field of DIS3-AID cells representing the conditions shown in Figure 4F.  In each field, the individual cell 
used in Figure 4F is boxed.  Note that 24.6% of cells contain EXOSC10 puncta at the 4h time point (based on a 
random count of 191 cells, within 13 fields of view across replicates).
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Figure S4: Inactive EXOSC10 causes dominant negative stabilisation of rRNA precursors, related to Figure 
5
(A) Western blotting of EXOSC10 in EXOSC10-AID cells or EXOSC10-AID cells stably expressing either wild-
type (WT) or inactive EXOSC10 (CAT).  In each case, samples show cells treated or not with auxin (1h).  This 
demonstrates the selective depletion of only the AID tagged version.  
(B) Northern blotting of the same cell lines and conditions in (A) whereby mature 5.8S rRNA (lower panel) or the 
3’ extended version (upper panel) were detected.  The 3’ extended version is also detected by the mature probe (*).  
Note that expression of inactive EXOSC10 has a dominant negative effect on the accumulation of the 3’ extended 
form, consistent with our iCLIP whereas expressing the WT protein has no such effect (compare lanes 1, 5 and 7).
(C) iCLIP track of 45S rRNA locus showing iCLIP read density obtained from EXOSC10WT or EXOSC10CAT.  
iCLIP reads are obtained across the whole locus but there is a striking accumulation of reads 3’ of the 5.8S gene in 
the EXOSC10CAT sample.  Units are reads per million mapped.  Lower track is zoomed to the 5’ETS sequence 
making it clear that there are sites of EXOSC10 binding, some of which are modestly enhanced in EXOSC10CAT
samples.  Units are reads per million mapped.
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Figure S5: Analysis of snoRNA 3’ extensions upon EXOSC10 or DIS3 loss, related to Figure 5
(A) Table summarising the percentage of expressed snoRNAs bound by either EXOSC10WT or EXOSC10CAT.
(B) IGV track of SNORA21 and SNORD13 in EXOSC10-AID and DIS3-AID cells treated or not with auxin.  
SNORA21 shows a longer 3’ extension when DIS3 is depleted and a shorter one when EXOSC10 is lost. 
SNORD13 also shows extended stabilisation upon loss of DIS3 and, more mildly, EXOSC10.  SNORD13 was the 
only example we found showing longer extensions in both cell lines.
(C) Table showing the proportion of iCLIP reads in the WT and CAT experiment that correspond to PROMPT, 
eRNA, 5’ flank of snoRNA, mature snoRNA or 3’ flank of snoRNA.  Also shown is the uplift (or not) in the 
proportion of reads as a result of using the inactive EXOSC10 (CAT/WT).  Bone fide substrates, exemplified by 3’ 
extended snoRNAs (red box), are more enriched in the CAT experiment.  However, PROMPTs and eRNAs are not 
enriched in this manner arguing that they are not normally EXOSC10 substrates – an observation supported by our 
RNA analyses.
(D) qRT-PCR analysis of PPM1G, SEPHS1 and RBM39 PROMPTs in EXOSC10-AID, EXOSC10-AID+WT or 
EXOSC10-AID+D313A cells treated or not with auxin (1h).  Values are shown relative to those obtained in 
untreated EXOSC10-AID cells after normalising to GAPDH levels.  Error bars are standard deviation.
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Figure S6: XRN2 plays no role in degrading PROMPT, eRNA or attenuated pre-mRNA, related to Figure 6
(A) MARS2 and SEPHS1 PROMPT regions in RNA-seq data obtained from XRN2-AID cells treated or not with auxin.
Note that there is a lack of XRN2 effect on PROMPT region RNAs (boxed) in both cases. “R1” and “R2” denotes two
biological replicates. Y-axis units are RPKM.
(B) Metaplot of promoter regions in RNA-seq data obtained from XRN2-AID cells treated or not with auxin. Note that
there is a general lack of XRN2 effect on PROMPT region RNAs consistent with our mNET-seq analyses in Figure 6.
(C) Tracks showing the same eRNA regions represented in Figure 3C in RNA-seq data obtained from XRN2-AID cells
treated or not with auxin. 8:8,290,610 shows no XRN2 effect. Whilst there is an enhanced anti-sense XRN2 effect for
X:45,705,862 this is due to a termination defect on a nearby micro RNA expressing gene and not due to eRNA
expression (part D of this figure). Note, that we have previously demonstrated that genes with 3’ microRNAs are subject
to XRN2-mediated termination (Eaton et al., 2018).
(D) IGV track of MIR222HG showing read-through transcription into the X:45,705,862 eRNA region (boxed) when
XRN2 is lost. This, not any role of XRN2 in eRNA stability, is responsible for the apparent increase in anti-sense signal
seen in part C of this figure. It is also consistent with our previous findings (Eaton et al., 2018) that XRN2 terminates
transcription following miRNA processing.
(D) Metaplot of eRNAs in RNA-seq data obtained from XRN2-AID cells treated or not with auxin. Note that there is a
general lack of XRN2 effect on eRNAs.
Amplicon Forward Reverse
PIGV US AAGGGGTTGTTGGGAAGTGA CCACTTGACCATGCTTGCAT
PIGV DS AGTTCAGGGCTTCACAGTGA
CTCAGGCCTCTAAACCCCA
A
PCF11 US TGACCATTCTAGCCGAGGAG
GGGGTTGGAGAGAAGGAAC
A
PCF11 DS CACACTGGCTCTGCACAAAT
CACACGAACATGCAGGAAG
T
PIGV SPL GACCCTAGAGAAGCCCGATC
CTCAACAGCGGCTCTTGAT
C
PCF11 SPL
TGAAGAAGAGGAGGAATGGC
A GGGTTCCTGCAATTCGTTTT
GAPDH SPL GCACCACCAACTGCTTAGC
ATGATGTTCTGGAGAGCCC
C
ACTB SPL CATCCGCAAAGACCTGTACG CCTGCTTGCTGATCCACATC
PPM1G GCCTGGCCAAGTACTTCCTA CCTCTTCCTTCGTTCCCAGT
STK11IP GGGAGTCTAAGGAAAAGGAG
CAGTGAAAGGAGAGCGTAT
C
SERPINB8 ACCAAGCAAAGGAGTCAGGA ACGTCCACCCAAACATTCTC
RBM39 GGAAATAGTGGAGAAAAGCA CATTTTTGAAGGAACGGTAG
FOXP4-AS TGCACAATTTCACACCTAGA ATGTTAGTGACACCTGCACA
SEPHS1 
PROMPT TCTCCACATTTCACGAGGCT
ATTTGCACAGGAGGCTAGG
A
DIS3 SPL
ACCCTCACTTAAAATAGAAGA
TACAGT
CCATTAAGGTCCATGTTTGA
AGT
CLIP4 SPL
ATTTTCTGCTTCTGATACCCC
A CCCACTGTCTCAAAATGGCA
CLIP4 US GTCAGGCTGTTCACGTCATC TTTCAAAGGCGCCCGTTTTA
CLIP4 DS
TCCTTTGTTTGGAAGATACCC
A
GGCGTAACAGAGAAGTCAA
GT
SEPHS1 SPL GGAAACATGTTCGGCCTCAT
CTATGATTCTGGCTGTGCG
G
SEPHS1 US TGAGCGCCTTCCTGATACAA TTTAACACAGCCTCACCCCT
SEPHS1 DS GGTGTCATGTGAACCTGCAG
CTGCCAGCGAATCAAGTGA
A
Table S1: oligonucleotides used for qRT-PCR, related to STAR METHODS
Name Sequence
iCLIP Oligo: L3 3’ RNA 
adapter 5’Phosphate-UGAGAUCGGAAGAGCGGUUCAG-3’Puromycin 
iCLIP Oligo: rtCLIP_5
5’Phosphate-
NNCGCCNNNAGATCGGAAGAGCGTCGTGgatcCTGAACCGC
iCLIP Oligo: Cut_oligo GTTCAGGATCCACGACGCTCTTCaaaa
iCLIP Oligo: P5Solexa 
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACG
CTCTTCCGATCT
iCLIP Oligo: P3Solexa 
CAAGCAGAAGACGGCATACGAGATCGGTCTCGGCATTCCTGCTGAA
CCGCTCTTCCGATC
5.8S Northern probe GCAAGTGCGTTCGAAGTGT
5.8S 3’ EXT Northern probe GGGGCGATTGATCGGCAA
Table S2: oligonucleotides used for iCLIP and Northern blot probe sequences, related to STAR METHODS
